Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012–2013 and 2013–2014

Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults

(2016) Carlos A. DiazGranados et al.   CLINICAL INFECTIOUS DISEASES

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

(2016) Edward A Belongia et al.   LANCET INFECTIOUS DISEASES

Controlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment

(2015) Leah J. McGrath et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis

(2015) Hector S Izurieta et al.   LANCET INFECTIOUS DISEASES

Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty

(2015) Carlos A. DiazGranados et al.   VACCINE

Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines

(2015) Carlos A. DiazGranados et al.   VACCINE

Antiviral Treatment among Older Adults Hospitalized with Influenza, 2006-2012

(2015) Mary Louise Lindegren et al.   PLoS One

Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic

(2014) Laurina O. Williams et al.   JOURNAL OF CLINICAL VIROLOGY

Influenza Vaccine Effectiveness in the United States During 2012-2013: Variable Protection by Age and Virus Type

(2014) H. Q. McLean et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

(2014) Carlos A. DiazGranados et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

(2014) Danuta M. Skowronski et al.   PLoS One

WHO recommendations for the viruses used in the 2013–2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013

(2014) Ian G. Barr et al.   VACCINE

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

(2013) Janet E McElhaney et al.   LANCET INFECTIOUS DISEASES

Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008

(2012) Hong Zhou et al.   CLINICAL INFECTIOUS DISEASES

Why do covariates defined by International Classification of Diseases codes fail to remove confounding in pharmacoepidemiologic studies among seniors?

(2011) Michael L. Jackson et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Minimizing Bias Due to Confounding by Indication in Comparative Effectiveness Research

(2010) Bruce M. Psaty et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older

(2009) Ann R. Falsey et al.   JOURNAL OF INFECTIOUS DISEASES

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

(2009) Peter C. Austin   STATISTICS IN MEDICINE